These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9604463)
1. Prolonged remission of urticaria pigmentosa following topical steroid therapy under hydrocolloid occlusion. Sidhu S; Wakelin SH; Wojnarowska F Clin Exp Dermatol; 1997 Nov; 22(6):302-3. PubMed ID: 9604463 [No Abstract] [Full Text] [Related]
2. Treatment of chronic idiopathic urticaria with topical steroids. An open trial. Ellingsen AR; Thestrup-Pedersen K Acta Derm Venereol; 1996 Jan; 76(1):43-4. PubMed ID: 8721491 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment. Glade CP; van der Vleuten CJ; van Erp PE; van de Kerkhof PC Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965 [TBL] [Abstract][Full Text] [Related]
4. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704 [TBL] [Abstract][Full Text] [Related]
5. Treatment of hand dermatosis: a comparative study of a topical glucocorticoid ointment vs solution occluded with a new thin hydrocolloid dressing. Beitner H Acta Derm Venereol; 1996 Sep; 76(5):408-9. PubMed ID: 8891026 [No Abstract] [Full Text] [Related]
9. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation. Mommers JM; van Erp PE; van De Kerkhof PC Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842 [TBL] [Abstract][Full Text] [Related]
10. A superpotent topical steroid for constricting breast cancer symptoms. Cheville A; Gonzales GR J Pain Symptom Manage; 1999 Mar; 17(3):149-52. PubMed ID: 10098354 [No Abstract] [Full Text] [Related]
11. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513 [TBL] [Abstract][Full Text] [Related]
12. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Rigopoulos D; Ioannides D; Prastitis N; Katsambas A Acta Derm Venereol; 2002; 82(2):140. PubMed ID: 12125946 [No Abstract] [Full Text] [Related]
13. Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Guzzo C; Lavker R; Roberts LJ; Fox K; Schechter N; Lazarus G Arch Dermatol; 1991 Feb; 127(2):191-6. PubMed ID: 1990983 [TBL] [Abstract][Full Text] [Related]
14. [Phimosis can be treated with local steroids]. Ruud E; Holt J Tidsskr Nor Laegeforen; 1997 Feb; 117(4):513-4. PubMed ID: 9148449 [TBL] [Abstract][Full Text] [Related]
15. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis. Theeuwes M; Bright R Cutis; 1996 Jan; 57(1):48-50. PubMed ID: 8620686 [TBL] [Abstract][Full Text] [Related]
17. Topical corticosteroids. Med Lett Drugs Ther; 1991 Nov; 33(857):108-10. PubMed ID: 1943979 [No Abstract] [Full Text] [Related]
18. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid. Claudy A Clin Dermatol; 2001; 19(6):778-80. PubMed ID: 11705688 [No Abstract] [Full Text] [Related]
19. Clobetasol--a potent new topical corticosteroid. Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267 [No Abstract] [Full Text] [Related]
20. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments. Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]